“Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids”, Reumatismo, vol. 65, no. 6, pp. 286–291, Mar. 2014, doi: 10.4081/reumatismo.2013.691.